Biote (BTMD) vs Altria Group (MO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Altria Group (MO) has outperformed Biote (BTMD) over the past year, gaining 4.1% versus a loss of 60.9%. Over five years, MO leads with a +42.5% price change compared with -88.6% for BTMD. Altria Group is the larger company by market cap ($115.85 billion vs $37.6 million), about 3078.7 times the size.
On valuation, Biote trades at a lower forward P/E (2.5x vs 11.8x for Altria Group). Altria Group pays a dividend yielding 6.11%, while Biote does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | MO |
|---|---|---|
| Share price | $1.11 | $69.38 |
| Market cap | $37.63M | $115.85B |
| 1-day change | -2.63% | +1.21% |
| YTD return | -57.31% | +20.33% |
| 1-year return | -60.92% | +4.10% |
| 5-year return | -88.64% | +42.46% |
| P/E ratio (TTM) | 7.93 | 14.61 |
| Forward P/E | 2.47 | 11.83 |
| EPS (TTM) | $0.14 | $4.75 |
| Dividend yield | 0.00% | 6.11% |
| Annual dividend | $0.00 | $4.24 |
| Revenue (latest FY) | — | $23.28B |
| Revenue growth (YoY) | — | -3.08% |
| Net income (latest FY) | — | $6.95B |
| Gross margin | — | 62.47% |
| Operating margin | — | 42.52% |
| Net margin | — | 29.84% |
| 52-week high | $3.26 | $77.06 |
| 52-week low | $1.09 | $54.70 |
| Distance from 52-week high | -65.95% | -9.97% |
| Analyst consensus | — | hold |
| Avg. price target upside | — | +0.89% |
| Average volume | 230.27K | 8.48M |
| Shares outstanding | 28.68M | 1.67B |
| Employees | — | 5,900 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Altria Group is about 3078.7 times larger than Biote by market value ($115.85B vs $37.63M).
- MO has outperformed BTMD by 65.0 percentage points over the past year.
- Altria Group trades at a higher earnings multiple (14.6x vs 7.9x trailing P/E).
- Altria Group offers a meaningfully higher dividend yield (6.11% vs 0.00%).
About Altria Group
MO stock →Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Health Care · Medicinal Chemicals and Botanical Products · 5,900 employees
BTMD vs MO FAQ
Which is bigger, Biote or Altria Group?
Altria Group (MO) is larger, with a market capitalization of $115.85B compared with $37.63M for Biote (BTMD).
Which stock has performed better over the past year, BTMD or MO?
MO returned +4.10% over the past 12 months, compared with -60.92% for BTMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BTMD or MO?
BTMD has the lower trailing P/E at 7.9, versus 14.6 for MO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Biote or Altria Group?
Altria Group pays a dividend yielding 6.11%, while Biote does not currently pay a regular dividend.
Are Biote and Altria Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.